News Detail
![](pdf/dacazee500160724081502.jpg)
Chennai, 16 July 2024: The Drugs Control Administration (DCA) in Telangana has filed a case against one Himachal Pradesh based drug manufacturer under the Essential Commodities Act, 1955 for violation of Drug Price Control Orders (DPCO).
The role of the marketing......
View Details
Source : Pharmabiz
Drugs Control Administration
DCA
Essential Commodities Act
drug price control orders
DPCO
anti-cancer drug
Dacazee 500 injection
dacarbazine
NPPA
MRP
Hodgkin’s disease
skin cancer
National List of Essential Medicines
NLEM 2022
Related News
- Yeida to hire consultant for medical devices park (17-07-2024)
- Medical devices import grows 13 per cent in 2023-24 (17-07-2024)
- CCPA slaps Rs 10 lakh fine on firm selling ayurvedic oil through ‘misleading’ advertisements (17-07-2024)
- Fake cancer drugs case: Accused worked for top hospitals, eight patients traced: Delhi Police (17-07-2024)
- Focus on 113 home-grown, affordable medical devices to cut down import dependence, says govt (16-07-2024)
- Health ministry to amend D&C Rules to include excipient details on labels (16-07-2024)
- First toll-free national anti-narcotics helpline to be launched (16-07-2024)
- Orthopaedic implants worth ₹70L seized by FDA (16-07-2024)
- SC upholds NPPA's Rs 4.65 cr recovery from Sun Pharma for 'Roscilox' (16-07-2024)
- Centre frames draft rules for compounding of offences under Drugs & Cosmetics Act (15-07-2024)